WhichRecall
Class IIIReported 2025-12-24

Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.

Recalled by SOMERSET THERAPEUTICS LLC

Reason for Recall

Subpotent product:out of specification assay results observed during long term stability testing.

Advertisement
Recall Number
D-0237-2026
Classification
Class III
Status
Ongoing
Category
drug
Initiated
2025-11-26
Reported
2025-12-24
Distribution
Nationwide in the USA
Code Info
Lot #: A250020, Exp Date 06/30/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement